Geographic · Tax Credit Carryforward, Valuation Allowance
Other countries — Tax Credit Carryforward, Valuation Allowance
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2025
Rolls up toTax Credit Carryforward Valuation Allowance
How to read this metric
A rising allowance suggests uncertainty regarding the company's ability to generate sufficient tax liability in foreign regions to utilize these credits.
Detailed definition
The valuation allowance applied to tax credit carryforwards generated in international jurisdictions. This reflects the...
Peer comparison
Standard tax credit valuation disclosure for multinational companies with complex global tax structures.
Metric ID:
ew_segment_other_countries_tax_credit_carryforward_valuation_allowanceHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.90M | $3.80M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +31.0% | -100.0% | — | — |
| YoY Change | — | +31.0% | -100.0% | — | — |
Range$0.00 – $3.80M
CAGR-100.0%
Avg YoY Growth-34.5%
Median YoY Growth-34.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's other countries — tax credit carryforward, valuation allowance?
- Edwards Lifesciences (EW) reported other countries — tax credit carryforward, valuation allowance of $0.00 in Q4 2025.
- What does other countries — tax credit carryforward, valuation allowance mean?
- The portion of international tax credits that the company does not expect to be able to use.